McKesson Net Income 2010-2022 | MCK

McKesson annual/quarterly net income history and growth rate from 2010 to 2022. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • McKesson net income for the quarter ending June 30, 2022 was $0.768B, a 58.02% increase year-over-year.
  • McKesson net income for the twelve months ending June 30, 2022 was $1.396B, a 131.04% decline year-over-year.
  • McKesson annual net income for 2022 was $1.114B, a 124.54% decline from 2021.
  • McKesson annual net income for 2021 was $-4.539B, a 604.33% decline from 2020.
  • McKesson annual net income for 2020 was $0.9B, a 2547.06% increase from 2019.
McKesson Annual Net Income
(Millions of US $)
2022 $1,114
2021 $-4,539
2020 $900
2019 $34
2018 $67
2017 $5,070
2016 $2,258
2015 $1,476
2014 $1,263
2013 $1,338
2012 $1,403
2011 $1,202
2010 $1,263
2009 $823
McKesson Quarterly Net Income
(Millions of US $)
2022-06-30 $768
2022-03-31 $368
2021-12-31 $-7
2021-09-30 $267
2021-06-30 $486
2021-03-31 $666
2020-12-31 $-6,226
2020-09-30 $577
2020-06-30 $444
2020-03-31 $1,021
2019-12-31 $186
2019-09-30 $-730
2019-06-30 $423
2019-03-31 $-796
2018-12-31 $469
2018-09-30 $499
2018-06-30 $-138
2018-03-31 $-1,146
2017-12-31 $903
2017-09-30 $1
2017-06-30 $309
2017-03-31 $3,588
2016-12-31 $633
2016-09-30 $307
2016-06-30 $542
2016-03-31 $431
2015-12-31 $634
2015-09-30 $617
2015-06-30 $576
2015-03-31 $132
2014-12-31 $472
2014-09-30 $469
2014-06-30 $403
2014-03-31 $370
2013-12-31 $65
2013-09-30 $404
2013-06-30 $424
2013-03-31 $259
2012-12-31 $298
2012-09-30 $401
2012-06-30 $380
2012-03-31 $521
2011-12-31 $300
2011-09-30 $296
2011-06-30 $286
2011-03-31 $422
2010-12-31 $155
2010-09-30 $327
2010-06-30 $298
2010-03-31 $348
2009-12-31 $326
2009-09-30 $301
2009-06-30 $288
2009-03-31 $281
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $52.490B $263.966B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $75.203B 21.85
AmerisourceBergen (ABC) United States $31.524B 13.92
West Pharmaceutical Services (WST) United States $25.249B 38.44
Laboratory Of America Holdings (LH) United States $24.048B 10.52
Cardinal Health (CAH) United States $18.885B 13.70
Cooper (COO) United States $16.482B 25.37
CONMED (CNMD) United States $3.143B 30.98
Invacare (IVC) United States $0.036B 0.00